What is Cardiac Cryoablation Ablation Catheter Market?
Cryoablation of the heart the FlexCath Advance Steerable Sheath and CryoConsole are used in conjunction with the Catheters as part of the Arctic Front Cardiac Cryoablation Catheter System. Catheters, which are small, flexible tubes that are placed through veins or arteries, are most frequently used during cardiac ablation procedures. Ablation is occasionally carried out during cardiac surgery. Depending on the regulation or hospital policies, a catheter lab may or may not be required. However, regulatory organizations like the FDA and others must approve catheter designs and their corresponding process methodologies. Through cryoablation, the pulmonary veins' ability to transmit harmful electrical signals to the atria is stopped.
Highlights from Cardiac Cryoablation Ablation Catheter Market Study
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | Medtronic Inc. (Ireland), Articure Inc. (United States), Boston Scientific (United States), St Jude Medical (United States), GE Healthcare (United States), Siemens (Germany), Angiodynamics (United States), Cameron Health (United States), Articure (United States) and Elmiko Medical (Poland) |
The global cardiac cryoablation ablation catheter market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. Key vendors with a prominent share in the global market are concentrating on escalating their client base around the world. These market players are leveraging on strategic collaborative creativities to intensify their market share and escalation their profitability. Key vendors operating in the global market are also acquiring start-ups.
Medtronic Inc. (Ireland), Articure Inc. (United States), Boston Scientific (United States), St Jude Medical (United States), GE Healthcare (United States), Siemens (Germany), Angiodynamics (United States), Cameron Health (United States), Articure (United States) and Elmiko Medical (Poland) are some of the key players profiled in the study. Cardiac Cryoablation Ablation Catheter Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Hospital and Clinics |
Type | Atrial Flutter Ablation, AV node Ablation, Pulmonary Vein Isolation, SVT Ablation and Others |
On the basis of geography, the market of Cardiac Cryoablation Ablation Catheter has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Advancement and Introduction of Healthcare Devices
Market Growth Drivers:
Increasing Geriatric Population over the Globe and Growing Awareness towards Treatment of Heart Conditions
Challenges:
Concerns with the Low-Quality Devices
Restraints:
Stringent Regulations on the Cardiac Cryoablation Ablation Catheter Application
Opportunities:
Rising Number of Patients Suffering from Cardiovascular Diseases
Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Cardiac Cryoablation Ablation Catheter Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries
On 9th November 2021, Medtronic plc launched of Arctic Front Cardiac Cryoablation Catheter System in India. To isolate the pulmonary vein, the Medtronic cryoballoon catheter was created expressly for the purpose. With strong safety and effectiveness data from more than 1200 peer-reviewed studies, this ground-breaking method has been utilized to treat more than 1,000,000 patients in more than 80 countries.